Physician profile
Jill A Pocius
NPI 1962625236
$2,931.65
in general payments reported to CMS, 2019-2025
20 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $154 · 2023: $400 · 2024: $610 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $700.71 | 2021-2025 | Belbuca, Xtampza, Nucynta |
| Nevro Corp. | $392.44 | 2021-2024 | Senza |
| Janssen Pharmaceuticals, INC | $383.96 | 2024-2025 | Spravato |
| Spinal Simplicity, LLC | $318.77 | 2023-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $264.29 | 2021-2025 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.57 | 2021-2025 | Relistor |
| Globus Medical, INC. | $147.30 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $124.87 | 2024 | Keytruda |
| Fidia Pharma USA INC. | $102.33 | 2023-2024 | Triluron, Hymovis, Hyalgan |
| Almatica Pharma LLC | $66.31 | 2021 | |
| Valinor Pharma, LLC | $55.68 | 2025 | Movantik |
| Biodelivery Sciences International, INC. | $49.19 | 2021 | |
| Abbott Laboratories | $33.83 | 2021 | |
| Lilly USA, LLC | $24.02 | 2021 | |
| Abbvie INC. | $19.33 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $15.38 | 2025 | Zynrelef |
| Curonix LLC | $14.62 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $14.07 | 2025 | Tirosint, Licart, Flector |
| Electronic Waveform Lab, INC. | $12.22 | 2024 | |
| Uswm, LLC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Pocius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.